Clinomics Inc. (KOSDAQ:A352770) announces a share repurchase program. Under the program, the company will repurchase up to 124,764 common stock. The purpose of the share repurchase is to adjust the number of shortfall stocks subject to exchange due to changes in the exchange price of exchangeable bonds subject to exchange for treasury stocks is added to the management account of the Korea Securities Depository.

The repurchase program will expire on August 30, 2023. As of August 29, 2023, the company had no shares within scope available for dividend and had 46,110 shares in treasury through other repurchase.